» Articles » PMID: 24158437

Glycolytic ATP Fuels the Plasma Membrane Calcium Pump Critical for Pancreatic Cancer Cell Survival

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2013 Oct 26
PMID 24158437
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic cancer is an aggressive cancer with poor prognosis and limited treatment options. Cancer cells rapidly proliferate and are resistant to cell death due, in part, to a shift from mitochondrial metabolism to glycolysis. We hypothesized that this shift is important in regulating cytosolic Ca(2+) ([Ca(2+)]i), as the ATP-dependent plasma membrane Ca(2+) ATPase (PMCA) is critical for maintaining low [Ca(2+)]i and thus cell survival. The present study aimed to determine the relative contribution of mitochondrial versus glycolytic ATP in fuelling the PMCA in human pancreatic cancer cells. We report that glycolytic inhibition induced profound ATP depletion, PMCA inhibition, [Ca(2+)]i overload, and cell death in PANC1 and MIA PaCa-2 cells. Conversely, inhibition of mitochondrial metabolism had no effect, suggesting that glycolytic ATP is critical for [Ca(2+)]i homeostasis and thus survival. Targeting the glycolytic regulation of the PMCA may, therefore, be an effective strategy for selectively killing pancreatic cancer while sparing healthy cells.

Citing Articles

Gemcitabine-loaded chitosan nanoparticles enhanced apoptotic and ferroptotic response of gemcitabine treatment alone in the pancreatic cancer cells in vitro.

Aydemir D, Ozturk K, Arslan F, Calis S, Ulusu N Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(11):9051-9066.

PMID: 38884675 PMC: 11522156. DOI: 10.1007/s00210-024-03193-6.


Driver Mutations of Pancreatic Cancer Affect Ca Signaling and ATP Production.

Stopa K, Lozinski F, Kusiak A, Litewka J, Krzysztofik D, Mosiolek S Function (Oxf). 2023; 4(5):zqad035.

PMID: 37575483 PMC: 10413928. DOI: 10.1093/function/zqad035.


PMCA inhibition reverses drug resistance in clinically refractory cancer patient-derived models.

Park K, Kim J, Kim S, Kim S, Lim J, Kim M BMC Med. 2023; 21(1):38.

PMID: 36726166 PMC: 9893610. DOI: 10.1186/s12916-023-02727-8.


Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma.

Okuno K, Xu C, Pascual-Sabater S, Tokunaga M, Takayama T, Han H Biomedicines. 2023; 11(1).

PMID: 36672630 PMC: 9855441. DOI: 10.3390/biomedicines11010119.


The modulation of ion channels in cancer chemo-resistance.

Zhao J, Li M, Xu J, Cheng W Front Oncol. 2022; 12:945896.

PMID: 36033489 PMC: 9399684. DOI: 10.3389/fonc.2022.945896.


References
1.
Koong A, Mehta V, Le Q, Fisher G, Terris D, Brown J . Pancreatic tumors show high levels of hypoxia. Int J Radiat Oncol Biol Phys. 2000; 48(4):919-22. DOI: 10.1016/s0360-3016(00)00803-8. View

2.
Rossi J, Rega A . A study to see whether phosphatidylserine, partial proteolysis and EGTA substitute for calmodulin during activation of the Ca2+-ATPase from red cell membranes by ATP. Biochim Biophys Acta. 1989; 996(3):153-9. DOI: 10.1016/0167-4838(89)90241-0. View

3.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

4.
Kim J, Ahn K, Kim J, Kim H, Lee J, Lee J . Role of reactive oxygen species-mediated mitochondrial dysregulation in 3-bromopyruvate induced cell death in hepatoma cells : ROS-mediated cell death by 3-BrPA. J Bioenerg Biomembr. 2008; 40(6):607-18. DOI: 10.1007/s10863-008-9188-0. View

5.
Hug M, Pahl C, Novak I . Evidence for a Na+-Ca2+ exchanger in rat pancreatic ducts. FEBS Lett. 1996; 397(2-3):298-302. DOI: 10.1016/s0014-5793(96)01185-4. View